Robert’s practice focuses on domestic and international patent prosecution, portfolio strategy and intellectual property (IP) due diligence in the field of life sciences. He leads the development and implementation of patent portfolio strategies that maximize the breadth and length of patent exclusivity to help his clients achieve their strategic business objectives. Robert also assists his clients in conducting patentability, invalidity, freedom-to-operate and noninfringement analyses to minimize their IP-related risks.
